Treatment with EGFR inhibitors has been reported as neuroprotective in rat models of glaucoma (Liu et al, 2006) and spinal cord injury (Erschbamer et al, 2007) by acting preferentially on reactive astrocytes. This evidence concerns the gene EGFR and glaucoma.